Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can chlamydia be stopped?

David M Ojcius1, Toni Darville, Patrik M Bavoil

  • 1University of California, USA.

Scientific American
|May 11, 2005
PubMed
Summary

Chlamydia is a common sexually transmitted infection that can lead to blindness and heart disease. New research offers innovative strategies to control its widespread transmission and impact.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A <i>Chlamydia trachomatis</i> CPAF-STING agonist conjugate vaccine administered intramuscularly and intradermally is immunogenic in the pig model.

Frontiers in immunology·2026
Same author

Genetic diversity of collaborative cross mice enables the establishment of a novel <i>Chlamydia muridarum</i> female genital tract infection model.

Infection and immunity·2026
Same author

A microphysiologic human cervical model recapitulates microbial, immune, and pathogenic properties of sexually transmitted infections.

Science advances·2026
Same author

Lactic acid drives NLRP3 inflammasome activation and caspase-1-like cytokine cleavage via intracellular acidification.

Cell death & disease·2026
Same author

Preconception <i>Mycoplasma genitalium</i> Seropositivity and Risk of Impaired Fecundity.

medRxiv : the preprint server for health sciences·2026
Same author

miRNA/mRNA analysis of increased TGF-β pathways drive epithelial-mesenchymal transition and regulatory T cell differentiation.

Frontiers in immunology·2026

Area of Science:

  • Infectious Diseases
  • Ophthalmology
  • Cardiology

Background:

  • Chlamydia is a widespread sexually transmitted infection (STI) with significant public health implications.
  • It is the leading preventable cause of blindness globally and is increasingly linked to cardiovascular conditions.
  • Current control measures face challenges due to asymptomatic infections and treatment resistance.

Purpose of the Study:

  • To explore novel therapeutic targets and preventative strategies against Chlamydia infections.
  • To investigate the link between Chlamydia and heart disease, seeking to understand the underlying mechanisms.
  • To identify new diagnostic and public health approaches for managing Chlamydia.

Main Methods:

  • Review of recent epidemiological data on Chlamydia prevalence and complications.
  • Analysis of emerging research on Chlamydia pathogenesis and host immune responses.
  • Evaluation of novel vaccine candidates and antimicrobial treatments in preclinical and clinical studies.

Main Results:

  • Emerging evidence highlights specific bacterial factors and host immune pathways involved in Chlamydia-associated blindness and cardiovascular disease.
  • Promising results from early-stage trials of new Chlamydia vaccines and targeted antimicrobial therapies.
  • Identification of potential biomarkers for early detection and risk stratification.

Conclusions:

  • Recent scientific advancements offer promising new avenues for controlling Chlamydia infections and their severe sequelae.
  • Further research is crucial to translate these discoveries into effective public health interventions for preventing blindness and heart disease.
  • A multi-faceted approach combining નવી (new) prevention, diagnostics, and therapeutics is essential to combat the global burden of Chlamydia.

Related Experiment Videos